In summary, these findings reveal that Cyp8b1-/- mice with a BA pool abundant in MCAs are protected against the development of several stigmata of the metabolic syndrome such as body and liver weight gain, steatosis, hypercholesterolemia and insulin resistance. Here, CYP8B1 is linked to metabolic syndrome.